Continuing Controversies in Staging NSCLC: An Analysis of the Revised 1997 Staging System

ONCOLOGY

Volumn 12, Issue 1 SUPPL. 2, 1998, Pages 51-54

  Ginsberg, Robert J ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER STAGING; CLASSIFICATION; HUMAN; LUNG NON SMALL CELL CANCER; LUNG TUMOR; LYMPH NODE; PATHOLOGY; PROGNOSIS;

CARCINOMA, NON-SMALL-CELL LUNG; HUMANS; LUNG NEOPLASMS; LYMPH NODES; NEOPLASM STAGING; PROGNOSIS;

EID: 0031611096     PISSN: 08909091     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. International Union Against Cancer: TNM Clussification of Malignant Tumaurs, 4th ed, pp 69-73. Bertin, Springer-Verlag, 1987.
2. International Union Against Cancer: TNM Classification of Malignant Tumours, 5th ed, pp 93-100. New York, Wiley-Liss, 1997.
3. American Joint Committee on Cancer (AJCC): Manual for Staging of Cancer, 3rd ed, pp 115-121. Philadelphia, J. B. Lippincott, 1988.
4. American Joint Committee on Cancer (AJCC): Manual for Staging of Cancer. 4th ed, pp 127-137. Philadelphia, J. B.Lippincott, 1997.
5. Martini N, Burt ME, Bains MS, et al: Survival after resection of stage II non-small-cell lung cancer. Ann Thorac Surg 54:460-466, 1992.
6. van Velzen E, Snijder RJ, Brutel de la Riviere A, et al: Lymph node type as a prognostic factor for survival in T2 N1 M0 non-small-cell lung carcinoma. Ann Thorac Surg 63:1436-1440, 1997.
7. Martini N, Bains M, Burt ME, et al: Incidence of local recurrence and second primary tumors in resected stage I lung cancer. J Thorac Surg 109:1-10, 1995.
8. McCaughan BC, Martini N, Bains MS, et al: Chest wall invasion in carcinoma of the lung. Therapeutic and prognostic implications. J Thorac Cardiovasc Surg 89:836-841, 1985.
9. Hata H: Resection of N2/N3 mediastinal disease, in Motta G (ed): Lung Cancer-Frontiers in Science and Treatment, pp 431-444. Genoa, Rapallo, 1993.
10. Lee JD, Ginsberg RJ: Lung cancer staging: The value of ipsilateral scalene lymph node biopsy performed at mediastinoscopy. Ann Thorac Surg 62:338-341, 1996.
11. Naruke T: Mediastinal lymph node dissection, in Pearson FG, Deslauriers J, Ginsberg RJ, et al (eds): Thoracic Surgery, pp 909-917. New York, Churchill Livingstone, 1995.
12. Wronski M, Arbit E, Burt M, et al: Survival after surgical treatment of brain metastases for lung cancer: A follow-up study of 231 patients treated between 1976-1991. J Neurosurg 83:605-616, 1995.
13. Naruke T, Sumasu K, Ishikawa S: Lymph node mapping and curability at various levels of metastasis in resected lung cancer. J Thorac Cardiovasc Surg 76:832-839, 1978.
14. American Thoracic Society: Clinical staging of primary lung cancer. Am Rev Respir Dis 127:1-6, 1983.
15. Rusch VW, Ginsberg RJ, Holmes EC: A Thoracic Surgical Handbook for Clinical Trials. New Jersey, Bristol-Myers Squibb, 1993.
16. Mountain CF, Dresler CM: Regional lymph node classification for lung cancer staging Chest 111(6):1718-1723, 1997.
17. Kern JA, Slebos RJC. Top B, et al: C-ErbB-2 expression and Codon 12 K-ras mutations both predict shortened survival for patients with pulmonary adenocarcinoma. J Clin Invest 93:516-520, 1994.
18. Minna JD, Sekido Y, Fong KW, et al: Molecular biology of lung cancer, in DeVita VT, Hellman S, Rosenberg SA (eds): Cancer: Principles and Practices of Oncology. 5th ed, pp 849-857. Philadelphia, Lippincott-Raven, 1996.
19. Ginsberg RJ, Yokes E, Raben A: Non-small-cell lung cancer, in DeVita VT, Hellman S, Rosenberg SA (eds): Cancer: Principles and Practice of Oncology, 5th ed, pp 858-911. Philadelphia, J. B. Lippincott-Raven, 1996.